Molecular Signatures of Nonalcoholic Fatty Liver Disease: The Present and Future

被引：0
|
作者：
Yilmaz, Yusuf [1 ]
Ulukaya, Engin [2 ]
机构：
[1] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey
[2] Uludag Univ, Sch Med, Dept Biochem, Bursa, Turkey
来源：
HEPATOLOGY | 2010年 / 51卷 / 05期
关键词：
METABOLIC SYNDROME; SERUM;
D O I：
10.1002/hep.23438
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1866 / 1866
页数：1
相关论文
共 50 条
  • [1] Past, present and future perspectives in nonalcoholic fatty liver disease
    Sanyal, Arun J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (06) : 377 - 386
  • [2] Past, present and future perspectives in nonalcoholic fatty liver disease
    Arun J. Sanyal
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 377 - 386
  • [3] The Future of Nonalcoholic Fatty Liver Disease Treatment
    Mazhar, Khurram
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (01) : 57 - +
  • [4] The Molecular Progression Of Nonalcoholic Fatty Liver Disease
    Cazanave, Sophie
    Podtelezhnikov, Alexei A.
    Seneshaw, Mulugeta
    Vincent, Robert
    Asgharpour, Amon
    Jensen, Kristian
    Tanis, Keith
    Webber, Andrea L.
    Wang, Liangsu
    Bedossa, Pierre
    Mirshahi, Faridoddin
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2016, 64 : 750A - 751A
  • [5] Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease
    Xu, Wanqiu
    Zhang, Zhengwei
    Yao, Lihong
    Xue, Bing
    Xi, Hualei
    Wang, Xiumei
    Sun, Shibo
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [6] Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease
    Fujiwara, Naoto
    Kubota, Naoto
    Crouchet, Emilie
    Koneru, Bhuvaneswari
    Marquez, Cesia A.
    Jajoriya, Arun K.
    Panda, Gayatri
    Qian, Tongqi
    Zhu, Shijia
    Goossens, Nicolas
    Wang, Xiaochen
    Liang, Shuang
    Zhong, Zhenyu
    Lewis, Sara
    Taouli, Bachir
    Schwartz, Myron E.
    Fiel, Maria Isabel
    Singal, Amit G.
    Marrero, Jorge A.
    Fobar, Austin J.
    Parikh, Neehar D.
    Raman, Indu
    Li, Quan-Zhen
    Taguri, Masataka
    Ono, Atsushi
    Aikata, Hiroshi
    Nakahara, Takashi
    Nakagawa, Hayato
    Matsushita, Yuki
    Tateishi, Ryosuke
    Koike, Kazuhiko
    Kobayashi, Masahiro
    Higashi, Takaaki
    Nakagawa, Shigeki
    Yamashita, Yo-ichi
    Beppu, Toru
    Baba, Hideo
    Kumada, Hiromitsu
    Chayama, Kazuaki
    Baumert, Thomas F.
    Hoshida, Yujin
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (650)
  • [7] Statins and nonalcoholic fatty liver disease: a bright future?
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (09) : 1089 - 1093
  • [8] Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Radwan, Mohamed M.
    Radwan, Basil M.
    Nandipati, Kalyana C.
    Hunter, William J., III
    Agrawal, Devendra K.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (08) : 727 - 738
  • [9] Treatment of Fatty Liver Disease: The Present and the Future
    Ramanan, Sruthi Priyavadhana
    Mohamed, Mohamed Wael F.
    Aung, Su Sandi
    Sange, Ibrahim
    Hamid, Pousette
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [10] Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
    Chae, Woori
    Lee, Kyung Jae
    Huh, Ki Young
    Moon, Jin Soo
    Ko, Jae Sung
    Cho, Joo-Youn
    [J]. METABOLITES, 2022, 12 (09)
12345